Investors of PepGen Inc. Urged to Join Securities Fraud Class Action Lawsuit

Potential Class Action Lawsuit for PepGen Investors

Recent developments have unfolded for investors in PepGen Inc. (NASDAQ: PEPG) as the Rosen Law Firm, a well-known global investor rights firm, has issued a reminder regarding a significant securities fraud class action lawsuit. If you purchased PepGen securities between March 7, 2024, and March 3, 2025, you may have the opportunity to participate in this class action and seek potential compensation.

Important Deadline to Remember

The lead plaintiff deadline is set for August 8, 2025. This means investors wishing to step forward and serve as lead plaintiffs must act before this date. Being a lead plaintiff allows one to represent the interests of other investors who have suffered losses during the class period. The urgency cannot be overstated, as timely action could lead to significant financial recovery for those affected.

How to Join the Class Action

For those interested in participating, joining the PepGen class action is straightforward. Individuals can visit the Rosen Law Firm's dedicated website—rosenlegal.com—or contact Phillip Kim, Esq. at 866-767-3653, or email [email protected]. This class action lawsuit has already been officially filed, and your prompt action could facilitate your role within it.

Insights on the Lawsuit

The Rosen Law Firm reports that PepGen's management allegedly made numerous misleading statements and omitted critical information that could have impacted investors’ decisions. Key points from the lawsuit outline claims that:

1. Ineffective and Unsafe Products: The drug PGN-EDO51 was purportedly less effective than represented.
2. Dangerous Clinical Studies: Issues arose surrounding the CONNECT2 study, which was reportedly unfit for FDA approval.
3. Overstated Prospects: Assertions about PepGen's regulatory and commercial prospects were exaggerated, leading to a significant disconnect between reality and investor perceptions.

4. Damaged Investor Trust: Consequently, as the truth began to surface, many investors faced substantial financial losses, sparking the lawsuit's development.

Choosing the Right Legal Representation

Rosen Law Firm emphasizes the importance of selecting legal counsel who possess a robust history of handling such cases successfully. While various firms provide notifications about class action opportunities, many lack the necessary resources and expertise. The Rosen Law Firm has established a reputation not just for navigating securities class actions but also for achieving significant settlements for their clients, including a record-breaking deal against a Chinese company. Ranking consistently high on various legal standings indicates their effectiveness in the space.

In 2019 alone, the Rosen Law Firm secured over $438 million for investors, showcasing a strong track record in recovering funds for affected parties. This level of success underlines why potential class members should consider their counsel carefully and opt for a firm with proven accomplishments.

Future Steps

Currently, no class has been certified, which means that investors are not represented by any legal counsel unless they decide to retain one. Investors have the option to either join the class action or remain silent and await developments. However, it's important to recognize that participation is not necessary for potential financial recovery, as benefits will be available irrespective of lead plaintiff status.

For more information and updates, interested parties can follow Rosen Law Firm on LinkedIn, Twitter, and Facebook. Remember, the process is contingent on timely actions, and the upcoming deadline is critical.

Investors are encouraged to take advantage of this opportunity to potentially recover losses through the class action process. If you are a PepGen investor, now is the time to act.